 | • レポートコード：QYR9NV17964 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、遺伝性疾患用遺伝子治療の世界市場について調査・分析し、遺伝性疾患用遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他）、用途別（病院、診療所、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の遺伝性疾患用遺伝子治療市場動向 ・主要企業別マーケットシェア ・遺伝性疾患用遺伝子治療の種類別市場規模2014-2019 （眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他） ・遺伝性疾患用遺伝子治療の用途別市場規模2014-2019 （病院、診療所、研究所、その他） ・遺伝性疾患用遺伝子治療の北米市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療の中国市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療の日本国内市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療のインド市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （BioMarin Pharmaceutical Inc.、bluebird bio Inc.、Novartis AG、Orchard Therapeutics Plc、Spark Therapeutics Inc.） ・遺伝性疾患用遺伝子治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.
In 2018, the global Gene Therapy for Inherited Genetic Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gene Therapy for Inherited Genetic Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Inherited Genetic Disorders development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
…
Market segment by Type, the product can be split into
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Market segment by Application, split into
Hospital
Clinic
Research Institute
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Therapy for Inherited Genetic Disorders status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy for Inherited Genetic Disorders development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gene Therapy for Inherited Genetic Disorders are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (2014-2025)
1.4.2 Eye Disorders
1.4.3 Hematological Disorders
1.4.4 Central Nervous System Disorders
1.4.5 Muscular Disorders
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Therapy for Inherited Genetic Disorders Market Size
2.2 Gene Therapy for Inherited Genetic Disorders Growth Trends by Regions
2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Regions (2019-2025)
2.2.2 Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Gene Therapy for Inherited Genetic Disorders Market Size by by Players
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by by Players (2014-2019)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by by Players (2014-2019)
3.1.3 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served
3.3 Key Players Gene Therapy for Inherited Genetic Disorders Product/Solution/Service
3.4 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2014-2019)
4.2 Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2014-2019)
5 North America
5.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
5.2 Gene Therapy for Inherited Genetic Disorders Key Players in North America
5.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type
5.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application
6 Europe
6.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
6.2 Gene Therapy for Inherited Genetic Disorders Key Players in Europe
6.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type
6.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application
7 China
7.1 China Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
7.2 Gene Therapy for Inherited Genetic Disorders Key Players in China
7.3 China Gene Therapy for Inherited Genetic Disorders Market Size by Type
7.4 China Gene Therapy for Inherited Genetic Disorders Market Size by Application
8 Japan
8.1 Japan Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
8.2 Gene Therapy for Inherited Genetic Disorders Key Players in Japan
8.3 Japan Gene Therapy for Inherited Genetic Disorders Market Size by Type
8.4 Japan Gene Therapy for Inherited Genetic Disorders Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
9.2 Gene Therapy for Inherited Genetic Disorders Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type
9.4 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application
10 India
10.1 India Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
10.2 Gene Therapy for Inherited Genetic Disorders Key Players in India
10.3 India Gene Therapy for Inherited Genetic Disorders Market Size by Type
10.4 India Gene Therapy for Inherited Genetic Disorders Market Size by Application
11 Central & South America
11.1 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
11.2 Gene Therapy for Inherited Genetic Disorders Key Players in Central & South America
11.3 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Type
11.4 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Application
12 International Players Profiles
12.1 BioMarin Pharmaceutical Inc.
12.1.1 BioMarin Pharmaceutical Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy for Inherited Genetic Disorders Introduction
12.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019))
12.1.5 BioMarin Pharmaceutical Inc. Recent Development
12.2 bluebird bio Inc.
12.2.1 bluebird bio Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy for Inherited Genetic Disorders Introduction
12.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
12.2.5 bluebird bio Inc. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy for Inherited Genetic Disorders Introduction
12.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Orchard Therapeutics Plc
12.4.1 Orchard Therapeutics Plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy for Inherited Genetic Disorders Introduction
12.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
12.4.5 Orchard Therapeutics Plc Recent Development
12.5 Spark Therapeutics Inc.
12.5.1 Spark Therapeutics Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy for Inherited Genetic Disorders Introduction
12.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
12.5.5 Spark Therapeutics Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Gene Therapy for Inherited Genetic Disorders Key Market Segments
Table Key Players Gene Therapy for Inherited Genetic Disorders Covered
Table Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Eye Disorders Figures
Table Key Players of Eye Disorders
Figuer Hematological Disorders Figures
Table Key Players of Hematological Disorders
Figuer Central Nervous System Disorders Figures
Table Key Players of Central Nervous System Disorders
Figuer Muscular Disorders Figures
Table Key Players of Muscular Disorders
Figuer Others Figures
Table Key Players of Others
Table Global Gene Therapy for Inherited Genetic Disorders Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Research Institute Case Studies
Figure Others Case Studies
Figure Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions 2014-2019
Figure Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions 2014-2019
Figure Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Gene Therapy for Inherited Genetic Disorders Revenue by by Players (2014-2019) (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Share by by Players (2014-2019)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Share by by Players in 2018
Table Global Gene Therapy for Inherited Genetic Disorders by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Therapy for Inherited Genetic Disorders Product/Solution/Service
Table Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2014-2019) (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Type (2014-2019)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2014-2019)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2014-2019) (Million US$)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Application (2014-2019)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application in 2018
Figure North America Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table North America Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table North America Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table North America Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table North America Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table North America Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table North America Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure Europe Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure China Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table China Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table China Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table China Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table China Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table China Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table China Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure Japan Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table Japan Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table Japan Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table Japan Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table Japan Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure India Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table India Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table India Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table India Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table India Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table India Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table India Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Figure Central & South America Gene Therapy for Inherited Genetic Disorders Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Therapy for Inherited Genetic Disorders Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Therapy for Inherited Genetic Disorders Market Share (2018-2019)
Table Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Type 2014-2019 (Million US$)
Table Central & South America Gene Therapy for Inherited Genetic Disorders Market Share by Type 2014-2019
Table Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Application 2014-2019 (Million US$)
Table Central & South America Gene Therapy for Inherited Genetic Disorders Market Share by Application 2014-2019
Table BioMarin Pharmaceutical Inc. Company Details
Table BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business 2014-2019 (Million US$)
Figure BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
Table BioMarin Pharmaceutical Inc. Recent Development
Table bluebird bio Inc. Company Details
Table bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business 2014-2019 (Million US$)
Figure bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
Table bluebird bio Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
Table Novartis AG Recent Development
Table Orchard Therapeutics Plc Company Details
Table Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business 2014-2019 (Million US$)
Figure Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
Table Orchard Therapeutics Plc Recent Development
Table Spark Therapeutics Inc. Company Details
Table Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business 2014-2019 (Million US$)
Figure Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
Table Spark Therapeutics Inc. Recent Development
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Regions (2019-2025)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Regions in 2025
Figure North America Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Therapy for Inherited Genetic Disorders Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size by Product (2019-2025)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size by Product in 2025
Table Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2025)
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
遺伝性疾患用遺伝子治療のグローバル市場：規模・現状・予測2019-2025 In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.Gene therapy has the potential to cure i…- 中枢神経系疾患の治療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Scope of the Report: This report studies the Central Nervous System Disorders Therapeutics market status and outlook of Global and majo…
- 神経障害治療法のグローバル市場：規模・現状・予測2019-2025 A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, con…
- 神経障害治療法のグローバル市場：規模・現状・予測2019-2025 A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, con…
- 自己免疫疾患治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Scope of the Report: This report studies the Autoimmune Disorders Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autoimmune Disorders Treatment…